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Over the last decade, there has been significant advances in the understanding of
the cross-talk between metabolism and immune responses. It is now evident that
immune cell effector function strongly depends on the metabolic pathway in which
cells are engaged in at a particular point in time, the activation conditions, and
the cell microenvironment. It is also clear that some metabolic intermediates have
signaling as well as effector properties and, hence, topics such as immunometabolism,
metabolic reprograming, andmetabolic symbiosis (among others) have emerged. Viruses
completely rely on their host’s cell energy and molecular machinery to enter, multiply,
and exit for a new round of infection. This review explores how viruses mimic, exploit or
interfere with host cell metabolic pathways and how, in doing so, they may evade immune
responses. It offers a brief outline of key metabolic pathways, mitochondrial function and
metabolism-related signaling pathways, followed by examples of the mechanisms by
which several viral proteins regulate host cell metabolic activity.
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INTRODUCTION
Several recent comprehensive reviews have highlighted the key role of eukaryotic cell metabolism
in immunity (Ganeshan and Chawla, 2014; O’Neill and Pearce, 2016; O’Neill et al., 2016). Six main
and interconnected metabolic pathways have a role in the immune response: glycolysis; the pentose
phosphate pathway (PPP); the tricarboxylic acid cycle (TCA), also known as Krebs cycle; the fatty
acid oxidation (FAO), also known as β-oxidation; as well as the fatty acid and amino acid synthesis
pathways (Figure 1).
Mitochondria take central stage in cellular metabolism since TCA, FAO, oxidative
phosphorylation (OXPHOS), calcium buffering, and heme biosynthesis take place within this
organelle (Mishra and Chan, 2016).
Energetic and biosynthetic metabolism is fueled by carbon sources, including glucose and
glutamine (DeBerardinis and Cheng, 2010), which are taken up by the cells by glucose and
glutamine transporters, respectively (Bhutia and Ganapathy, 2016; Navale and Paranjape, 2016).
Once in the cytosol, glucose is converted to pyruvate, via glycolysis, yielding two molecules
of ATP and two molecules of NADH (which acts as a cofactor in several enzymatic reactions)
per unit of glucose. The glycolysis pathway is also the source of biosynthetic intermediates
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that serve the purpose of ribose and nucleotides synthesis
(glucose-6-phosphate into ribulose 5-phosphate), amino acids
(3-phosphoglycerate enters the serine biosynthetic pathway), and
fatty acids (by the sequential conversion of glycolysis-derived
pyruvate into the TCA intermediate citrate that may be exported
from the mitochondria to the cytosol, where it is converted
into acetyl-coA).
Glycolysis-derived pyruvate is either converted to lactate,
which is exported out of the cells, or converted into acetyl-CoA
that enters the TCA cycle through the aldol condensation with
oxaloacetate to form citrate (O’Neill et al., 2016). Citrate is then
sequentially converted to isocitrate, α-ketoglutarate, succinyl
CoA, succinate, fumarate, malate, and oxaloacetate, which starts
Abbreviations: ACC, Acetyil-CoA carboxylase; Akt, Akt/Protein kinase B;
AMP, Adenosine monophosphate; AMPK, Adenosine monophosphate-activated
protein kinase; ATP, Adenosine three phosphate; 2B, 2B protein; 2BC,
2BC protein; ANT3, Adenine nucleotide translocator 3; ATLL, Adult T-
cell leukemia/lymphoma; BALF1, BamH1-A left frame transcript; BHRF1,
BamH1-Hright reading frame; BZLF1, Zebra protein; cGAS, cyclic guanosin
monophosphate-adenosin monophosphate synthase; cGMP, cyclic guanosine
monophosphate; CoA, Coenzyme A; CTL, Cytotoxic T lymphocytes; COXIII,
Cytochrome c oxidase III; 1ψm, Mitochondrial membrane potential; Drp1,
Dynamin-related protein; dTTP, Deoxythymidine triphosphate; early Zta, early
Zta protein; Env, Envelope; ER, Endoplasmic reticulum; FADH2, reduced Flavin
adenin dinucleotide; FAO, Fatty acid oxidation; FHV, Flock house virus; F17, F17
protein; Grb10, Growth factor receptor bound protein 10; HBx, Hepatitis B virus
x protein; HIF1α, Hypoxia-induced factor 1α; HPV 18, Human papillomavirus
18; KSHV, Kaposi’s sarcoma-associated herpesvirus; HSP60, Heat shock protein
60; IFI6-16, Interferon inducible protein 6-16; IFNs, Interferons; IκBα, nuclear
factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha;
IKK, IκB kinase; IL-4, Interleukin-4; IP3Rs, Inositol 1,4,5-triphosphate receptors;
IRF3, Interferon regulatory factor 3; ISGs, Interferon-stimulator genes; JAK-
STAT, Janus kinase-Signal transductor and activator of transcription; Lag-
3, Lymphocyte activation gene-3; LANA, Latency-associated nuclear antigen;
LMP2A, Latent membrane protein 2A; LPS, Lypopolysacharide; M1, Macrophage
type1; M2, Macrophage type 2; MAMs, Mitochondria-associated membranes;
MAVS, Mitochondrial antiviral-signaling protein; MCU, Mitochondrial calcium
uniporter; MDA-5, Melanoma differentiation-associated gene 5; Mfn1, Mitofusin
1; MHV68γHV68, Murine gammaherpesvirus-68; mTORC1, mechanistic target
of rapamycin complex 1; mTORC2, mechanistic target of rapamycin complex 2;
mtSSB, Mitochondrial single-stranded DNA binding protein; NADPH, reduced
Nicotinamide adenine dinucleotide phosphate; Nef, Nuclear elongation factor;
NS, Non-structural Proteins; NETs, Neutrophyl extracellular traps; NFκB, Nuclear
factor kappa B; NK, Natural killer; NLR, NOD-like receptor; NOD, Nucleotide-
binding and oligomerization domain; NS1, Non-structural protein 1; NS2b3,
Non-structural protein 2b3; OMM, outer mitochondrial membrane; OPA1,
Optic atrophy protein 1; ORF52, Open reading frame 52; OXPHOS, Oxidative
phosphorylation; PB1-F2, PB1-F2 protein; PB1-F2 66S, PB1-F2 protein, serine 66
PB1-F2 66N, PB1-F2 protein, asparagine 66; PB2, PB2 protein; PD-1, Programmed
death-1; PFK, Phosphofructokinase; PGC-1a, Peroxisome proliferator-activated
receptor-gamma coactivator-1alpha; PI3K, phosphatidylinositol 3-kinase; PLC,
Phospholipase C; PMA, Phorbol 12-myristate 13-acetate; PPP, pentose phosphate
pathway; PRRs, Pattern recognition receptors; p7, protein 7; p13, protein 13;
P70S6K, Ribosomal protein S6 kinase beta-1; RIG-1, Retinoic acid-induced gene
1; RLR, RIG-1-like Receptor; ROS, Reactive Oxygen Species; SPCA 1, Secretory
pathway calcium ATPase 1; STING, Stimulator of interferon genes; TBK1, TANK
binding kinase 1; TCA, Tricarboxylic acid; Tim-3, T cell immunoglobulin mucin-
3; TLRs, Toll like receptors; TTP, thymidine triphosphate; UL 12, full length
UL 12 protein; UL 12. 5, N-terminally truncated UL 12 protein; UPR, Unfolded
protein response; UTP, Uridine triphosphate; VV, Vaccinia virus; VDAC3, Voltage
dependent anion channel 3;VMC1, Viral mitochondrial carrier 1; vIRF1, viral
Interferon regulatory factor 1; vMIA, viral mitochondrial-localized inhibitor of
apoptosis. Note: Other viruses abbreviations are indicated in Tables 1–5.
a new round of the TCA cycle by its reaction with pyruvate-
derived acetyl CoA. Fatty acids can also be converted into acetyl
CoA through FAO, linking this metabolic pathway with the TCA
cycle. Two major products of both the TCA cycle and FAO
are NADH and FADH2, which can transfer electrons to the
mitochondrial electron transport chain coupled with OXPHOS
and the generation of ATP (O’Neill et al., 2016). In addition,
succinate, an intermediate in the TCA cycle, is also an electron
donor for the mitochondrial respiratory chain at complex II
(succinate dehydrogenase) (Rich and Maréchal, 2010).
The pentose phosphate pathway involves a non-oxidative
as well as an oxidative branch; the first allows for the
diversion from glycolysis intermediates toward the synthesis
of nucleotide and amino acid precursors, while the second
generates reducing equivalents of nicotinamide adenine
dinucleotide phosphate hydrogen (NADPH), which maintain
a favorable cellular redox environment and allows fatty acid
synthesis (O’Neill et al., 2016).
Fatty acid synthesis uses glycolysis, TCA cycle, and pentose
phosphate pathway metabolic intermediates. TCA cycle-derived
citrate may be exported from the mitochondria to the
cytosol and then ATP citrate lyase converts citrate to acetyl-
coA, which in turn may be carboxylated by acetyl-CoA
carboxylase (ACC) producing malonyl-CoA. Furthermore,
fatty acid synthase and NADPH elongate fatty acid chains
(O’Neill et al., 2016).
Glutamine is also a primary source of energy as it is converted
to glutamate and then to α-ketoglutarate, which enters the TCA
cycle (DeBerardinis and Cheng, 2010).
Immune system cells preferentially follow one or other
metabolic pathway, depending on cell type, differentiation
status, activation conditions, and microenvironment.
Resting T lymphocytes rely mostly on OXPHOS,
whereas activated and proliferating T lymphocytes
upregulate the expression of the glucose transporter
glut-1 and key glycolytic enzymes, relying mostly on
glycolysis (Frauwirth et al., 2002; Pearce and Pearce, 2013).
Memory T lymphocytes use OXPHOS (Pearce and Pearce,
2013), “classically activated” macrophages (stimulated with
LPS plus IFN-γ)—also referred to as M1 macrophages—
engage in glycolysis, whereas alternatively activated
macrophages (stimulated with IL-4)—also referred to as
M2 macrophages—use OXPHOS and FAO to generate
energy (Rodríguez-Prados et al., 2010). Stimulated
macrophages and dendritic cells engage in glycolysis after
activation through pattern recognition receptors (PRRs)
(O’Neill and Pearce, 2016).
Neutrophils rely mostly on glycolysis (Pearce and
Pearce, 2013) and the release of neutrophil extracellular
traps (NETs) is dependent on the increase in cell
membrane glut-1, glucose uptake, and the glycolytic
rate (Rodriguez-Espinosa et al., 2015).
Activated B lymphocytes undergo metabolic reprogramming
in response to changing energetic and biosynthetic demands,
and long-lived plasma cells uptake glucose and glutamine at
a higher rate; glucose is used to generate pyruvate for spare
respiratory capacity, and glutamine is used as a carbon source for
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FIGURE 1 | Eukaryotic cell metabolism. Bioenergetic and biosynthetic pathways interconnect glycolysis, glutaminolysis, PPP (pentose phospahate pathway), TCA
(tricarboxylic acid cycle), FAO (fatty acid oxidation), fatty acid synthesis, aminoacid synthesis, metabolic sensors such as the AMPK, mTORC1, and mTORC2
pathways, and are also dependent on calcium homeostasis, mitochondrial membrane potential and mitochondrial dynamics. All together they influence cell function
and may be the targets of several viruses.
mitochondrial anaplerotic reactions and respiration, promoting
cell survival (Jellusova and Rickert, 2016; Lam et al., 2018).
Switching metabolic pathways (metabolic reprograming)
leads to changes in cell function (Buck et al., 2017) and the
metabolic microenvironment, i.e., tissue O2 tension, or the
concentration of metabolites such as lactate determines cell
immune responses (Romero-Garcia et al., 2016).
Interestingly, viral infections such as ocular infection with
herpes simplex virus-1 (HSV-1) may change blood glucose
levels in the course of infection (Varanasi et al., 2017).
Moreover, if glucose utilization is pharmacologically limited
in vivo in the inflammatory phase, lesions diminish but, if
glucose utilization is limited in the acute phase of infection
when the replicating virus is still present in the eye, infected
mice become susceptible to the lethal effects of HSV-1
infection as the virus spreads to the brain, causing encephalitis
(Varanasi et al., 2017). This highlights the fundamental
relationship between cell metabolism, immune response, and
viral pathogenesis.
ANTI-VIRAL IMMUNE RESPONSES
Among the most effective antiviral immune responses is the
production of several type I interferons (Figure 2); interferon-
α (IFN-α) subtypes and interferon-β (IFN-β), which along with
IFN-ε, IFN-τ , IFN-κ, IFN-ω, IFN-δ, and IFN-ζ, are collectively
referred to as type I interferons; most cells can produce IFN-α
and IFN-β following cell activation through the recognition of
viral nucleic acids (McNab et al., 2015).
The RIG-I-MDA5-mitochondrial antiviral-signaling protein
(MAVS) axis is the major sensing pathway for RNA viruses,
while the axis composed of the cyclic guanosine monophosphate
(cGMP)-adenosinemonophosphate (AMP) synthase (cGAS) and
the stimulator of interferon genes (STING) is the major sensing
pathway for DNA viruses (Wu and Chen, 2014). However,
there is recent evidence that the cGAS-STING pathway may
also restrict the infection by RNA viruses, thus suggesting a
connection between the sensing of cytosolic DNA and RNA
(Ni et al., 2018).
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FIGURE 2 | Antiviral immune responses. Type I interferons, cell cytotoxicity, neutrophil extracellular traps and neutralizing antibodies protect against viral infections,
each type of response has a metabolic hallmark. Viruses may target specific metabolic pathways for immune evasion.?, not known.
Both anti-viral pathways converge in the activation of two
main transcription factors that regulate the expression of type-
I interferons, nuclear factor kappa B (NFκB) and interferon
regulatory factor 3 (IRF3). In the case of the RIG-I-MDA5-MAVS
pathway, their activation depends on mitochondrial function
(Seth et al., 2005; Koshiba, 2013).
Both IFN-α and IFN-β activate the expression of interferon-
stimulated genes (ISGs) through the Janus kinase-signal
transducer and activator of transcription (JAK-STAT) signaling
pathway, leading to the inhibition of viral replication and
assembly (Darnell et al., 1994; Seth et al., 2005).
Cytotoxic T lymphocytes (CTL) play an important role in
the clearance of viral infections (Figure 2); memory CTL can
be activated by low concentrations of antigen, readily producing
cytokines and the lysis of infected cells, thus preventing
dissemination (Veiga-Fernandes et al., 2000).
Upon acute viral infection, virus-specific memory CTL
quickly produce IFN-γ. However, around 18 h after infection
the number of IFN-γ producing CTL drops concomitantly with
the upregulation of inhibitory receptors. It has been suggested
that the decrease in the synthesis of IFN-γ by CTL is an active
regulatory process (Hosking et al., 2013) reminiscent of T cell
exhaustion, a process also known to take place during chronic
viral infections (Yi et al., 2010; Wherry, 2011).
A hallmark of T cell exhaustion is the upregulation of
inhibitory receptors such as programmed death-1 (PD-1), T cell
immunoglobulin mucin-3 (Tim-3), and lymphocyte activation
gene-3 (Lag-3) (Freeman et al., 2000; Barber et al., 2006).
Interestingly, PD-1 negatively regulates glycolysis, represses
the transcriptional co-activator peroxisome proliferator-
activated receptor-gamma co-activator (PGC)-1alpha
(PGC-1α), which plays an important role in the regulation
of carbohydrate and lipid metabolism, and impairs CTL
responses (Bengsch et al., 2016).
Other anti-viral cell-mediated immune responses
include NK cell cytotoxicity (Hammer et al.,
2018) and neutrophil extracellular traps (NETs)
(Schönrich and Raftery, 2016) (Figure 2).
Natural killer (NK) cells have anti-viral activities as they exert
direct cytotoxicity on virus infected-cells, and readily produce
IFN-γ. NK cells increase their glycolytic rate upon activation
(Gardiner and Finlay, 2017), and disruption of glycolysis impairs
NK cell-mediated responses to Cytomegalovirus (CMV), for
instance (Mah et al., 2017).
Neutrophils are considered a first line of defense against
pathogens. However, their role in the control of viral infections is
not as clear as for other pathogens (Galani and Andreakos, 2015).
It has recently been recognized that viruses can induce the release
of neutrophil extracellular traps (NETs), and the mechanisms
by which NETs could contribute to anti-viral immunity are
emerging (Hammer et al., 2018).
Several viruses, including Hantaan virus (HTNV), H1N1
Influenza A virus (IAV), human immunodeficiency virus (HIV-
1), and Respiratory Syncytial virus (RSV), directly stimulate
neutrophils to release NETs (Raftery et al., 2014; Delgado-Rizo
et al., 2017), and both IFN-α and IFN-γ can prime mature
neutrophils to release NETs upon further stimulation (Martinelli
et al., 2004; Hammer et al., 2018).
HIV-1 may also prevent the release of NETs by inducing
dendritic cells to produce IL-10, which in turn suppresses the
reactive oxygen species (ROS)-dependent release of NETs (Saitoh
et al., 2012; Hammer et al., 2018).
The Dengue virus serotype-2 (DENV-2) down-modulates the
phorbol 12- myristate 13- acetate-(PMA) induced release of
NETs, and it has been proposed that one of the mechanisms
for this is the interference with the mobilization of the glucose
transporter glut-1 to the cell membrane and consequently with
the glucose uptake (Moreno-Altamirano et al., 2015).
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NETs may prevent virus spreading by being trapped by
electrostatic attraction or be inactivated by molecules associated
with NETs, such as myeloperoxidase and α-defensins (Saitoh
et al., 2012; Hammer et al., 2018).
Antibodies are also important anti-viral effectors (Figure 2),
and whereas cytotoxic lymphocytes can eliminate infected cells,
antibodies are capable of both eliminating infected cells and
neutralizing viruses, thereby preventing cell infection. The
production of protective antibodies over prolonged periods
constitutes a first line of defense against reinfection and,
therefore, survival of antibody-producing plasma cells is
determinant (Dörner and Radbruch, 2007). It is now known that
plasma cell longevity is dependent on enhanced glut-1 expression
and glucose uptake, mitochondria pyruvate import and spare
respiratory capacity, and that nutrient uptake and catabolism
distinguish plasma cell subsets with different lifespans and rates
of secreted antibodies (Lam et al., 2016, 2018).
Taken together, it emerges that the activity of immune system
cells is dependent on cell metabolism and that viruses could target
cell metabolism to evade anti-viral immune responses. The next
sections explore some specific mechanisms by which viruses may
interfere with cell metabolism.
MITOCHONDRIAL ANTI-VIRAL SIGNALING
(MAVS) AND VIRUS SUBVERSION
OF MAVS
Mitochondria constitute a metabolic hub, so if a virus is to take
control of host metabolism, targeting mitochondria is perhaps
the best way.
In 2005 Seth et al. reported the identification of a new protein
essential for the activation of the transcription factors NFκB
and IRF3 by RNA viruses. They named the protein MAVS and
showed that this contains a C-terminal transmembrane domain
that targets the mitochondrial outer membrane. Strikingly, they
found that this transmembrane domain and the targeting to
mitochondria are essential for MAVS signaling, opening a new
avenue of research in which mitochondria took center stage in
antiviral immunity (Seth et al., 2005).
In non-stimulated cells, NFκB is located in the cytoplasm,
associated with its inhibitor IκBα. Upon stimulation with viruses,
other pathogens or cytokines, the IκB kinase (IKK) is activated,
leading to the phosphorylation of IκBα and its subsequent
ubiquitination and proteasomal degradation. NFκB is then
released and translocated to the nucleus, where it activates
immune and inflammatory genes (Silverman andManiatis, 2001;
Seth et al., 2005).
IRF3 is located in the cytoplasm of non-stimulated cells,
and following viral or other pathogen infection it becomes
phosphorylated by TANK-binding kinase 1 (TBK1) and IKK
kinases, allowing the formation of homodimers that can
translocate into the nucleus and activate the synthesis of IFN-β,
acting in synergy with NFκB (Yoneyama et al., 2002; Fitzgerald
et al., 2003; Hiscott et al., 2003; Seth et al., 2005).
IRF7 can also be phosphorylated by TBK1 and IKK (tenOever
et al., 2004), leading to the production of interferon-α (Honda
et al., 2005; Seth et al., 2005). NFκB and IRFs are activated by
RNA viruses as well as by other pathogens.
The entry of RNA viruses to the cells produces double-
stranded RNA intermediates, which can be recognized by host
cell pathogen recognition receptors (PRRs) including TLR -3, -7,
-8, and -9 (Akira and Takeda, 2004; Seth et al., 2005).
The receptor Retinoic Acid-Induced Gene I (RIG-
1) recognizes intracellular dsRNA and the interaction
of viral RNA with RIG-1 leads to a change in its
conformation, which then activates NFκB and IRF3
(Yoneyama et al., 2002; Sumpter et al., 2005).
The melanoma differentiation-associated gene 5 (MDA5) is
a RIG-I-like protein involved in dsRNA signaling and apoptosis
(Kovacsovics et al., 2002; Seth et al., 2005).
In 2011, Koshiba (Koshiba, 2013) demonstrated that
mitochondrial fusion and mitochondrial membrane potential
(1ψm) are required for MAVS-mediated signaling. They
showed that the deletion-targeting of mitofusin 1 (Mfn1) and
mitofusin 2 (Mfn2), two molecules involved in mitochondrial
fusion, prevented cells from producing interferons and pro-
inflammatory cytokines in response to viral infection. This
resulted in increased viral replication along with a reduced1ψm,
correlating with a reduced antiviral response. Interestingly, the
reduction in 1ψm did not affect the activation of IRF3, which
acts downstream of MAVS, suggesting that 1ψm and MAVS
are coupled at the same stage in the RIG-1-like Receptor (RLR)
signaling pathway (Koshiba, 2013).
In addition to mitochondria, MAVS are also found in
peroxisomes and mitochondrial-associated membranes (MAMs)
(Seth et al., 2005; Vazquez and Horner, 2015).
A natural target for the subversion of IFN type I-mediated
antiviral response is the MAVS protein (Table 1). As an example,
the influenza A virus encodes a protein called PB1-F2, which
inhibits the induction of type I interferon at the level of the
MAVS (Varga et al., 2012). PB1-F2 is an 87–90-amino-acid-long
protein with a serine at position 66 (66S), which accounted for the
virulence of the Spanish and avian flu pandemic viruses (H1N1
and H5N1, respectively). Interestingly, PB1-F2 66S has a higher
affinity for MAVS than PB1-F2 66N, and more efficiently affects
the1ψm than the wild-type PB1-F2 (Conenello et al., 2007).
TABLE 1 | Viruses that subvert MAVS.
Virus Viral
proteins
Effect References
Influenza A virus
(IAV)
PB1-F2 Inhibition of type I IFN
at the level of MAVS
Conenello et al.,
2007
Influenza A virus
H1N1(1918) and
H5N1
PB1-F2 66S,
PB1-F2 66N
Disruption of
mitochondrial
membrane potential
and type I IFN
response
Conenello et al.,
2007
Hepatitis C virus
(HCV)
NS3/4A Inhibition of type I IFN
response by cleaving
of MAVS
Meylan et al., 2005
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Other viruses, such as hepatitis C virus (HCV), induce the
cleavage of MAVS from the outer membrane of mitochondria,
reducing the interferon-producing response. In this case, the
NS3/4A protein cleaves MAVS at cysteine 508 (Meylan et al.,
2005; Bender et al., 2015; Vazquez and Horner, 2015).
Another family of pattern recognition receptors contain
a nucleotide-binding and oligomerization domain (NOD)
and is called the NLR (NOD-like receptor) family.
NOD2 facilitates the activation of IRF3 and the synthesis
of type I IFN in response to single-stranded RNA.
Interestingly, the activation of NOD2 is dependent on MAVS
(Sabbah et al., 2009; Moreira and Zamboni, 2012).
Recently, NLRX1 (also known as NOD5, NOD9, or NOD26),
a member of the NLR family that localizes to the outer
mitochondrial membrane, was shown to mediate MAVS
degradation, allowing HCV to evade type I IFN-mediated
antiviral response (Qin et al., 2017).
cGAS-STING ANTI-VIRAL PATHWAY AND
ITS SUBVERSION BY VIRUSES
The cyclic guanosine monophosphate (cGMP)-adenosine
monophosphate (AMP) synthase (cGAS) recognizes viral as
well as bacterial double-stranded DNA (dsDNA) (Wu and
Chen, 2014; Ni et al., 2018). After binding to dsDNA, cGAS
catalyzes the synthesis of the second messenger cyclic guanosine
monophosphate-adenosine monophosphate (cGAMP), which
then binds to the stimulator of interferon genes (STING)
adaptor protein on the endoplasmic reticulum (ER); STING,
as a dimer, translocates from the endoplasmic reticulum to the
Golgi complex, where it recruits TANK-binding kinase 1 (TBK1)
which activates the transcription factors NFκB and IRF3, both of
which translocate to the nucleus and induce the synthesis of type
I interferons (Barber, 2015; Ni et al., 2018).
While the activation of the RIG-1-MDA5-MAVS antiviral
signaling pathway clearly requires mitochondrial activity, in
the form of mitochondrial dynamics and 1ψm, a metabolism-
related component in the cGAS-STING antiviral signaling
pathway has not been explicitly identified. However, several
lines of research suggest crosstalk between cGAS-STING and
metabolism. Firstly, the ER has been regarded as a separate
metabolic compartment on the basis that the ER luminal micro-
environment is different from the cytosol, that it contains its
own pool of pyridine nucleotides, and that several metabolic
pathways related to carbohydrate and steroid metabolism,
biotransformation, and protein processing take place in the ER
(Csalaa et al., 2006); viral infections may lead to ER stress and
to the unfolded protein response (UPR) (Zhang and Wang,
2012); and the mitochondrial function in cells undergoing ER
stress is compromised, particularly at the level of mitochondrial
membrane potential, oxygen consumption, and ATP production
(Wang et al., 2011). The ER stress and UPR synergy with the
cGAS-STING antiviral signaling pathway still needs to be fully
elucidated (Smith, 2014).
Among the DNA viruses that activate the cGAS-STING
pathway are herpes simplex virus 1 (HSV-1), vaccinia virus (VV),
andmurine gamma herpesvirus 68 (MHV68). Interestingly, RNA
viruses such as HIV-1 generate RNA: DNA hybrids as well as
dsDNA that may activate the cGAS-STING pathway (Ma and
Damania, 2016; Ni et al., 2018).
Of note, dengue virus (DENV)-induced mitochondrial
damage leads to mitochondrial DNA release to the cytosol, and
the activation of the cGAS-STING pathway (Sun et al., 2007).
Since other viruses may cause mitochondrial damage (see below)
it is plausible that other RNA viruses may activate cGAS-STING
through mitochondrial DNA release.
Several DNA virus-associated proteins are known to
interfere with the cGAS-STING pathway, as reviewed
by Ni et al. (2018), either by interfering with DNA
binding to cGAS, as is the case of Kaposi’s sarcoma-
associated herpesvirus (KSHV), Epstein Barr virus (EBV),
and murine gammaherpesvirus-68 (MHV68,γHV68)
tegument protein open reading frame 52 (ORF52), and
the KSHV latency-associated nuclear antigen (LANA)
protein which interact with cGAS (Wu et al., 2015;
Zhang et al., 2016), or by targeting STING, as is the case
for the HSV-1-infected cell protein 27 (ICP27) and the
UL46 protein, the KSHV viral interferon regulatory factor 1
(vIRF1), the human papillomavirus 18 (HPV18) E7 oncoprotein,
the human adenovirus 5 (hAd5) E1A oncoprotein, and
the Hepatitis B virus (HBV) polymerase (Lau et al., 2015;
Liu et al., 2015; Ma et al., 2015; Christensen et al., 2016;
Deschamps and Kalamvoki, 2017).
A more recent development in the field is the finding that
some RNA viruses are also capable to interfere with the cGAS-
STING pathway, subverting its anti-viral effect (Ni et al., 2018).
Finally, it has been shown that single- or double-stranded
DNA may attenuate glucose metabolism, leading to ATP
depletion and so constitute a metabolic barrier for viral
replication. However, the mechanism seems to be dependent
on the activation of adenosine monophosphate (AMP)-activated
protein kinase (AMPK) and the activation of mechanistic target
of rapamycin complex 1 (mTORC1) (see below), but independent
of the cGAS-STING anti-viral pathway (Zheng et al., 2015).
MITOCHONDRIAL PROTEINS OTHER
THAN MAVS AS TARGETS OF
VIRAL INFECTION
Some viruses encode mitochondrial proteins, which allow them
a direct functional intervention on host cells mitochondria
(Table 2). In this regard, the Acanthamoeba polyphaga
mimivirus (APMV), one of the largest known viruses (400 nm
in its capside diameter) (La Scola et al., 2003; Monné et al.,
2007), encodes a mitochondrial transport protein called VMC1
(viral mitochondrial carrier), whose function is to transport
dATP and other nucleotide triphosphates (dTTP, TTP, UTP,
and ADP). VMC1 can support the replication of the APMV
genome by acquiring additional nucleotide triphosphates from
the mitochondrial pool in exchange for cytosolic ADP (Monné
et al., 2007). The APMV genome additionally encodes other five
putative mitochondrial proteins (Monné et al., 2007).
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TABLE 2 | Viruses that target other mitochondrial proteins.
Virus Viral
proteins
Effect References
Acantthamoeba
polyphaga
mimivirus
(APMV)
Virus
mitochondrial
carrier 1
(VMC1)
Increase of viral
replication by
transporting dATP
from the
motochondrial
pool
Monné et al., 2007
Epstein Barr
virus (EBV)
BHRF1,
BZLF1,
BALF1, early
Zta
Increase of viral
replication,
prevention of B
cell apoptosis,
blockage of mDNA
replication
Cavallari et al.,
2018
Hepatitis C virus
(HCV)
p7, NS3/4A,
NS5A
Disruption of
mitochondrial
function,
cleaveage of
MAVS
Cavallari et al.,
2018
Hepatitis C virus
(HCV)
Core Mitochondria
depolarization,
increased
production of
mitochondrial ROS
Cavallari et al.,
2018
Influenza virus
(IV)
PB1-F2, PB2,
NS1
Modulation of viral
replication, viral
mRNA synthesis
Cavallari et al.,
2018
Herpes simplex
virus-1 (HSV-1)
UL 12.5 Degradation of
mitochondrial DNA
early during
infection
Cavallari et al.,
2018
Herpes simplex
virus-1 (HSV-1)
UL 12 Generation of
mature viral
genomes
Cavallari et al.,
2018
The Human T-cell leukemia virus type 1 (HTLV-
1) causes adult T-cell leukemia/lymphoma (ATLL) and
encodes an 87-amino acid protein (p13) that helps this
virus to establish a persistent infection. This protein
primarily accumulates in the inner mitochondrial membrane
of host cells and alters mitochondrial morphology
toward a more rounded shape, fragments mitochondria
(mitochondrial fission), and reduces mitochondrial Ca2+ uptake
(Biasiotto et al., 2010; Cavallari et al., 2018).
Several proteins encoded by Epstein Barr virus (EBV) target
mitochondria, such as BHRF1 (BamHI-H right reading frame),
BZLF1 (also known as Zebra protein), BALF1 (BamHI-A
left frame transcript), LMP2A (Latent membrane protein),
and immediate early Zta protein. BHRF1 accumulates in the
outer mitochondrial membrane (OMM) of B lymphocytes,
preventing apoptosis and promoting survival of EBV-infected
cells, viral persistence, and replication; BHRF presents homology
with the transmembrane domains of some eukaryotic Bcl-
2 family members (Kvansakul et al., 2017; Cavallari et al.,
2018); and BZLF1 has the capacity to interact with mtSSB
(mitochondrial single-stranded DNA-binding protein), which
is required for the replication of the mitochondrial genome,
and partially redirects mtSSB from mitochondria to the
nucleus (LaJeunesse et al., 2005; Cavallari et al., 2018).
BALF1 also shares homology with Bcl-2 family members
and modulates apoptosis and promotes transformation
(Hsu et al., 2012; Cavallari et al., 2018). LMP2A induces
mitochondrial fission by a Drp1-dependent mechanism
(Pal et al., 2014; Cavallari et al., 2018), and finally, the
immediate early Zta protein can also bind mtSSB in the
cytoplasm, inducing its re-location to the nuclei, blocking
mitochondrial DNA replication and facilitating viral replication
(Wiedmer et al., 2008).
Many other viruses encode mitochondrial proteins capable
of regulating a broad spectrum of mitochondrial activities, as
reviewed by Cavallari et al. (2018), including the control of
intracellular Ca2+, apoptosis, mitochondrial dynamics, the levels
of cytochrome c oxidase III (COXIII) and COX activity, as well
as cellular ROS production, and the aggregation of mitochondria
near the nucleus. Others promote mitophagy and interfere with
the antiviral interferon response (Wu et al., 2007; Wang and
Ryu, 2010). Proteins such as KS-Bcl-2 localize in mitochondria
(Gallo et al., 2017), and others such as the KSHV-encoded K7
protein localize in mitochondria as well as in the ER and nucleus
(Feng et al., 2002).
The non-structural proteins p7 of HCV can modify the
mitochondrial function. The p7 protein is determinant for the
assembly and later release of infectious virions, it is capable
to form membrane-associated hexameric ion channels, induces
mitochondrial membrane depolarization, and binds to the
interferon inducible protein 6–16 (IFI6-16) (Nieva et al., 2012;
Madan and Bartenschlager, 2015; Qi et al., 2017); HepG2 cells
that express HCV core protein have increased levels of prohibitin,
a protein that regulates mitochondrial function and apoptosis
(Peng et al., 2015), by reducing the levels of COX subunits
I and II. Therefore, the interaction between the HCV core
protein and prohibitin may interfere with the assembly of the
respiratory chain, which could lead to increased production of
mitochondrial ROS and viral replication (Tsutsumi et al., 2009;
Ren et al., 2016). Other molecular partners for viral-encoded
mitochondrial proteins are voltage-dependent anion channel 3
(VDAC3) (Rahmani et al., 2000), and heat shock protein 60
(HSP60) (Tanaka et al., 2004).
Three influenza virus proteins are known to localize into
mitochondria: PB1-F2, PB2, and NS1 (Chen et al., 2001;
Yamada et al., 2004; Carr et al., 2006; Tsai et al., 2017).
Although PB1-F2 is dispensable for viral replication, at least
in some host cells, its expression accelerates influenza virus-
induced apoptosis in human monocytes through mitochondrial
ANT3 (adenine nucleotide translocator 3) and VDAC1 (voltage
dependent anion channel 1) (Chen et al., 2001; Zamarin
et al., 2005). The PB2 protein has a key role in viral mRNA
synthesis and localizes in mitochondria, where it can regulate
the viability of mitochondria during infection (Carr et al.,
2006). The NS1 protein is highly expressed in Influenza A
virus-infected cells, and predominantly localizes in the nucleus,
although it may also be found in the cytoplasm at later
stages of infection (Melén et al., 2007). Although NS1 does
not harbor mitochondria-targeting sequences, it has also been
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found in mitochondria at early times (1.5 h) post-infection
(Tsai et al., 2017).
The UL12 gene of herpes simplex virus type 1 (HSV-
1) encodes two distinct but related alkaline DNases through
two separately promoted 3’ co-terminal mRNAs, producing
full-length (UL12) and amino-terminal truncated (UL12.5)
proteins. UL12 localizes to the nucleus while UL12.5 is
predominantly located in mitochondria, where it degrades
mitochondrial DNA early during infection. Whereas nuclear-
targeted UL12 produces mature viral genomes from larger
genome precursors (Draper et al., 1986; Saffran et al., 2007;
Corcoran et al., 2009), the role of UL12.5 is not well-defined
since mitochondrial DNA degradation is not required for HSV-1
replication (Duguay et al., 2014).
MITOCHONDRIAL DYNAMICS
AND VIRUSES
Mitochondria constantly undergo fusion and fission depending
on the cell metabolic requirements, a process that has been
dubbed as mitochondrial dynamics (Mishra and Chan, 2016).
Along with being the “powerhouse” of eukaryotic cells,
mitochondria are also involved in cellular innate antiviral
immunity (Seth et al., 2005). Mitochondrial fusion and fission
processes depend on the activity of mitofusin 1 (Mfn1), mitofusin
2 (Mfn2), and optic atrophy protein 1 (OPA1)—which promotes
fusion—in addition to Dynamin-related protein 1 (Drp1)—
which promotes mitochondrial fission (Mishra and Chan, 2016).
There is evidence that antiviral immune responses can be
regulated by mitochondrial dynamics (Arnoult et al., 2011;
West et al., 2011). The close association between mitochondrial
dynamics and several mitochondrial and cellular functions
may suggest that mitochondrial dynamics could be a target
for viruses to interfere with immune responses (Table 3).
Likewise, the non-structural protein 4A (NS4A) from HCV,
either alone or associated with the non-structural protein 3
(NS3), accumulates in mitochondria, altering the mitochondrial
dynamics (Nomura-Takigawa et al., 2006). Infection with
HIV-1 re-shapes mitochondrial distribution within the cells
(Radovanovic´ et al., 1999), while African swine fever virus
(ASFV) induces the clustering of mitochondria around virus
factories within infected cells, providing the local energy required
for the release of virus (Rojo et al., 1998). The DENV NS2b3
protein partially cleaves Mfn1 and Mfn2, attenuating interferon
responses (Yu et al., 2015), and induces mitochondrial fusion
by inhibiting Drp1 activation and in turn the activation of the
interferon response (Chatel-Chaix et al., 2016).
Excessive mitochondrial fission may lead to mitochondrial
damage, and this may have a role in hepatitis B virus (HBV)-
induced liver disease (Kim et al., 2013).
Hepatitis B virus, through its HBx protein, triggers the
translocation of Drp1 to the mitochondria by stimulating the
phosphorylation of Drp1 at the Ser616 residue, and on the
other hand, contributes to the degradation of Mfn2, favoring
mitochondrial fission and mitophagy, attenuating the virus-
induced apoptosis in the process (Kim et al., 2013).
TABLE 3 | Viruses that disrupt mitochondrial dynamics.
Virus Viral proteins Effect References
Hepatitis C
virus (HCV)
NS4A, NS3 Change of
mitochondria
distribution
Nomura-Takigawa
et al., 2006
Human
immunodeficiency
virus-1 (HIV-1)
Clustering of
mitochondria
Radovanovic´
et al., 1999
African swine
fever virus
(ASFV)
Cluster of
mitochondria
around virus
factories, providing
ATP for virus
release
Rojo et al., 1998
Dengue virus
(DENV)
NS2b3 Cleavege of Mfn1
and Mfn2,
attenuation of IFN
responses
Yu et al., 2015
Mitochondrial
fusion by inhibition
of Drp1
Chatel-Chaix
et al., 2016
Hepatitis B
virus (HBV)
HBx Mitochondrial
fission, and
mitochondrial
injury
Kim et al., 2013
Intracellular calcium concentrations also regulate
mitochondrial dynamics since the calcium-dependent
phosphatase calcineurin dephosphorylates Drp1 at S637,
facilitating the recruitment of Drp1 to the mitochondria and the
consequent mitochondrial fission (Cereghetti et al., 2008).
INTRACELLULAR CALCIUM
HOMEOSTASIS AND VIRAL INFECTIONS
Intracellular calcium participates in cell signaling,
mitochondrial function, and cell death (Duchen,
2000; Contreras et al., 2010), and Ca2+ uptake by
mitochondria activates Krebs cycle enzymes and oxidative
phosphorylation, leading to higher ATP production
(Nasr et al., 2003).
Several viruses regulate host cell calcium concentrations
in the cytoplasm as well as in mitochondria, allowing viral
gene expression, virus replication, and the control of host cell
viability (Table 4). HSV1 downregulates the uptake of Ca2+ by
mitochondria along its lytic cycle, modulating virus replication
(Lund and Ziola, 1985). Other viruses such as HCV target
mitochondria, increasing Ca2+ concentration (Li et al., 2007;
Campbell et al., 2009). Among the HCV proteins known to
interfere with Ca2+ homeostasis, are the core protein, the NS5A,
and the p7 protein (Gong et al., 2001; Griffin et al., 2004;
Kalamvoki and Mavromara, 2004; Dionisio et al., 2009).
HBV induces the mobilization of Ca2+ from mitochondria
and endoplasmic reticulum to the cytoplasm through the
interaction of the HBV protein X with voltage-dependent
anion channels (VDAC) (Bouchard et al., 2001; Choi et al.,
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TABLE 4 | Viruses that disrupt calcium homeostasis.
Virus Viral proteins Effect References
Human T leukemia
virus (HTLV-1)
p13 p13 accumulates
in the inner
mitochondrial
membrane,
reduces Dym and
mCa2+ uptake
Biasiotto et al.,
2010
Herpes simplex
virus 1 (HSV1)
? Modulation of viral
replication by
down-regulation of
Ca2+ uptake by
mitochondria
Lund and Ziola,
1985
Hepatitis C virus
(HCV)
NS5A, p7 Increase of Ca2+
concentration
Gong et al., 2001;
Griffin et al., 2004
Hepatitis B virus
(HBV)
HBx Ca2+ release from
mitochondria and
ER
Bouchard et al.,
2001
Human
immunodeficiency
virus-1 (HIV-1)
Nef Increase in viral
replication by
IP3R-dependent
increase of
cytosolic Ca2+
Foti et al., 1999
Rotavirus NSP4 virus release by
decreasing Ca2+
concentration
Tian et al., 1995;
Ruiz et al., 2007
Poliovirus 2BC Increase in viral
gene expression
and apoptosis by
increse in Ca2+
concentration
Aldabe et al., 1997
Coxsackievirus B3 2B Control of
apoptosis and
virus release by
regulation of Ca2+
concentration
Campanella et al.,
2004
Human
cytomegalovirus
(HCMV)
pUL37x1 Increased viral
replication by
mitochondria
Ca2+ uptake and
increased ATP
Sharon-Friling
et al., 2006;
Bozidis et al.,
2010
?, not known.
2005). The HIV-1 protein Nef (nuclear elongation factor)
interacts with the Inositol 1,4,5-trisphosphate receptor (IP3Rs),
increasing cytosolic Ca2+ concentration, promoting the
transcription of virus-encoded genes and viral replication
(Kinoshita et al., 1997; Foti et al., 1999). Rotavirus, through
its NSP4 protein, activates phospholipase C (PLC) and the
release of Ca2+ from the endoplasmic reticulum to the cytosol.
However, by the end of its life cycle there is a decrease
in cellular Ca2+ concentrations enabling rotavirus release
(Tian et al., 1995; Ruiz et al., 2007; Díaz et al., 2008).
Poliovirus increases intracellular Ca2+ concentrations shortly
after infection, increasing viral gene expression (Irurzun et al.,
1995; Aldabe et al., 1997). By the end of the virus life cycle
Ca2+ accumulates within mitochondria at the expense of ER
stores in a mitochondrial calcium uniporter (MCU) and voltage-
dependent anion channel (VDAC)-dependent process, leading to
mitochondrial dysfunction and apoptosis (Brisac et al., 2010).
Enteroviruses control apoptosis through Ca2+ regulation; in
this way, low levels of cytosolic Ca2+ provide the conditions
for viral replication while high concentrations of cytosolic Ca2+
lead to the formation of vesicles which allow virus release
(Campanella et al., 2004; Van Kuppeveld et al., 2005).
Human cytomegalovirus (HCMV) protein pUL37 ×
1, also known as viral mitochondrion-localized inhibitor
of apoptosis (vMIA) localizes into mitochondria and
induces the transfer of ER Ca2+ into mitochondria,
increasing the production of ATP and virus replication
(Sharon-Friling et al., 2006; Bozidis et al., 2010).
The maturation of viral glycoproteins is dependent on both
pH and intracellular Ca2+ concentrations. Ca2+ acts as a
cofactor for several enzymes including glycosyl- and sulfo-
transferases (Vanoevelen et al., 2007). Measles virus (MV),
Dengue virus (DENV), West Nile virus (WNV), Zika virus
(ZIKV), and Chikungunya virus (CHIKV) use the host calcium
pump secretory pathway calcium ATPase 1 (SPCA1) for
Ca2+ loading into the trans Golgi network, which activates
glycosyl transferases and proteases allowing viral maturation and
spreading (Hoffmann et al., 2017).
mTOR AND AMPK AS METABOLIC HUBS
AND VIRAL TARGETS FOR EVASION
The mechanistic target of rapamycin (mTOR) and the
adenosine monophosphate-activated protein kinase (AMPK)
constitute an integrated metabolic sensor. High levels of
ATP (high ATP/AMP ratio) activate mTORC1, resulting
in enhanced nutrient-dependent protein synthesis, cell
growth and proliferation, whereas low levels of ATP
(low ATP/AMP and ATP/ADP ratios), a hallmark of
metabolic stress (starvation, hypoxia or viral infection),
lead to AMPK-mediated inhibition of mTORC1 and
activation of mTORC2, which restores energy homeostasis
by switching the ATP-consuming biosynthetic pathways
off and the ATP-producing catabolic pathways on
(Hardie et al., 2012; Saxton and Sabatini, 2017).
MTOR acts as the catalytic subunit of either of two molecular
complexes known as mTOR complex 1 (mTORC1) and mTOR
complex 2 (mTORC2); mTORC1 is bound to the protein Raptor
(Hara et al., 2002; Kim et al., 2002) and mTORC2 is bound to the
protein Rictor (Hresko and Mueckler, 2005).
MTORC1 induces metabolic reprograming from OXPHOS
to glycolysis by upregulating the transcription factor hypoxia-
induced factor 1α (HIF1α) and, as a result, increases the
expression of several glycolytic enzymes including phospho-
fructo kinase (PFK). On the other hand, mTORC2 regulates
cell proliferation and survival by activating the PI3K-Akt
pathway (Düvel et al., 2010; Thomanetz et al., 2013; Saxton
and Sabatini, 2017). The mTORC1 complex acts downstream
of Akt and, as a way of regulation, the mTORC1 substrate
p70S6K suppresses mTORC2, and the mTORC1 substrate Grb10
suppresses PI3K signaling (Hsu et al., 2011; Yu et al., 2011; Saxton
and Sabatini, 2017), establishing a negative feedback that balances
mTORC1 and mTORC2 activities (Meade et al., 2018).
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TABLE 5 | Viruses that target mTOR or AMPK.
Virus Viral proteins Effect References
Herpes simplex
virus 1 (HSV1)
viral kinase Us3 Enhancement of
mTORC1 activity
Martin et al., 2012
Poliovirus (PV) Inhibition of
mTORC1 activity
Human
immunodeficiency
virus-1 (HIV-1)
Env Activation of
mTORC1 activity
Le Sage et al.,
2016
Sindbis virus
(SINV)
Activation of
mTORC
Le Sage et al.,
2016
Chikungunya virus
(CHIKV)
? Controversial
activation/Inhibition
of mTOR
Le Sage et al.,
2016
Influenza A virus
(IAV)
NS1 Differential
activation of
mTORC1 and
mTORC2,
supports viral
replication
Kuss-Duerkop
et al., 2017
Andes virus
(ANDV)
glycoprotein Gn Activation of
mTOR, supports
viral protein
expression and
replication
McNulty et al.,
2013
Hepatitis C virus
(HCV)
NS5A Activation of
mTORC1
supports viral
protein expression
and replication
Stohr et al., 2016
Poxviruses F17 Evasion of
cytosolic sensing
by disruption of
the mTORC1-
mTORC2
circuit
Meade et al., 2018
Dengue virus
(DENV)
? Viral replication by
activation of AMPK
and inhibition of
mTORC1
Jordan and
Randall, 2017
Zika virus (ZIKV) ? AMPK activation
evokes antiviral
innate responses
and restricts virus
replication
Kumar et al., 2018
?, not known.
Extracellular growth factors, the cell energy status, and
different stressors such as viral infection are integrated into the
mTOR pathway. Not surprisingly, viruses can modulate mTOR
signaling to their advantage (Le Sage et al., 2016; Saxton and
Sabatini, 2017) (Table 5). HSV-1 can enhance mTORC1 activity;
whereas Poliovirus, HIV-1, Sindbis virus, and CHIKV can inhibit
this same complex (Martin et al., 2012).
Activation of mTORC1 supports viral protein expression and
replication of Influenza A virus, Andes virus (ANDV), and
HCV (McNulty et al., 2013; Stohr et al., 2016; Kuss-Duerkop
et al., 2017). On the other hand, poxviruses are capable of
evading their cytosolic sensing bymeans of a conserved structural
protein that disrupts the mTORC1-mTORC2 regulatory circuit
while maintaining the metabolic benefits of mTOR activity
(Meade et al., 2018).
DENV activates AMPK, decreases the activity of mTORC1,
and induces lipophagy, a process that is required for the
robust DENV replication; the autophagic-mediated mobilization
of lipids increases the β-oxidation in DENV-infected cells
(Jordan and Randall, 2017) whereas AMPK activation evokes
antiviral innate responses and restricts ZIKV replication
(Kumar et al., 2018).
CAN VIRUSES REPLICATE
WITHIN MITOCHONDRIA?
In addition to the interaction of viral proteins withmitochondria,
which modify mitochondrial function, the Alphanodavirus
flock house virus (FHV) can infect yeast, insect, plant, and
mammalian cells, and replicates its RNA in the mitochondrial
outer membrane. Miller et al. showed that the FHV RNA-
dependent RNA polymerase, required for FHV RNA replication,
localizes to the outer mitochondrial membrane and by electron
microscopy these authors identified 40–60 nmmembrane-bound
spherical structures, similar to other virus-induced membrane
structures, within the mitochondrial intermembrane space of
infected cells from Drosophila (Miller et al., 2001).
CONCLUDING REMARKS
This review explores how viruses may subvert immune responses
by controlling host cell metabolism.
Viruses may target MAVS (RIG-I-MDA5-MAVS anti-viral
pathway) interfering with RNA virus-induced type 1 interferon
responses and target other mitochondrial-associated proteins,
disrupting mitochondrial dynamics, mitochondrial membrane
potential, and calcium handling—all of which may affect anti-
viral immunity. They may also regulate the production of
ATP to their advantage by interfering with mitochondrial
calcium mobilization, mitochondrial enzymatic activities, and
key metabolic sensors such as mTORC1, mTORC2, and AMPK.
They may also induce cytotoxic T lymphocyte exhaustion, which
implies metabolic reprogramming.
Viruses may also target the cGAS-STING anti-viral pathway,
interfering with DNA virus-induced type I IFN responses. Since
this anti-viral pathway is not directly connected with host cell
metabolism (at least not in the way the RIG-I-MDA5-MAVS
is), one key outstanding question is why anti-RNA viruses IFN
responses are more “metabolically directed” compared to anti-
DNA virus responses. Moreover, why do some RNA viruses
induce the release of mitochondrial DNA and in this way recruit
the RIG-I-MDA5-MAVS pathway?
In the context of HCV infection, there are at least two
mechanisms accounting for the degradation of MAVS, direct
cleaving by the HCV-encoded NS3/4A protein, and the NLRX1-
induced proteosomal degradation. As both MAVS and NLRX1
localize in the outer mitochondrial membrane, and MAVS
signaling is dependent on mitochondrial function, it remains
to be determined whether NLRX1 activity is also dependent
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on mitochondrial function. However, it is currently known that
NLRX1 regulates OXPHOS and cell integrity in a model of
ischemia-reperfusion injury, and that loss of NLRX1 increases
oxygen consumption and oxidative stress in epithelial cells
(Stokman et al., 2017).
The role of glycolysis, β-oxidation, and oxidative
phosphorylation on viral infections is continuing to emerge, but
there are still outstanding questions on the role and mechanism
that some metabolic intermediates may play in viral infection.
For instance, dimethyl fumarate enhances the infection of cancer
cell lines and human tumor biopsies with several oncolytic
viruses (Selman et al., 2018), whereas ZIKV infection upregulates
the enzyme cis-aconitate descarboxylase, which converts the
TCA intermediate cis-aconitate to itaconate, an endogenous
inhibitor of succinate dehydrogenase, inhibiting the conversion
of succinate to fumarate and generating a metabolic state that
restricts ZIKV replication in neurons (Daniels et al., 2019). These
topics require further exploration.
On the other hand, the success of anti-viral antibody
responses as well as of antibody-mediated anti-viral vaccine
protection depends on plasma cell lifespan, which ultimately
relies on plasma cell metabolism; something that differs
from B lymphocyte metabolism (Lam et al., 2018). It would
therefore be interesting to determine whether there are viruses
that specifically target plasma cell metabolism, and in which
case whether protecting plasma cell metabolism could be
therapeutically useful in helping to support long-lasting anti-viral
immune responses.
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